Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ACON NASDAQ:DHAC NASDAQ:NIVF NASDAQ:VSEE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACONAclarion$7.30+0.4%$7.31$6.20▼$3,499.51$4.23M1.3493,966 shs6,349 shsDHACDigital Health Acquisition$0.87+4.8%$1.17$11.07▼$33.08$3.14M0.2340,215 shs46,314 shsNIVFNewGenIvf Group$1.75+4.8%$3.50$1.62▼$3,280.00$1.51M-0.09393,849 shs37,404 shsVSEEVSee Health$0.82-5.7%$1.16$0.62▼$3.54$2.95MN/A390,136 shs67,073 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACONAclarion+5.05%+3.58%-0.46%+10.54%-99.65%DHACDigital Health Acquisition0.00%-12.90%-43.72%-29.59%-55.69%NIVFNewGenIvf Group-5.38%-13.02%-39.72%-87.35%-99.80%VSEEVSee Health+4.82%+1.09%-38.30%-20.18%-50.85%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationACONAclarion1.5878 of 5 stars3.03.00.00.00.00.01.3DHACDigital Health AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ANIVFNewGenIvf GroupN/AN/AN/AN/AN/AN/AN/AN/AVSEEVSee Health1.5599 of 5 stars2.04.00.00.01.50.00.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACONAclarion 2.00Hold$11,758.50160,975.34% UpsideDHACDigital Health Acquisition 0.00N/AN/AN/ANIVFNewGenIvf Group 0.00N/AN/AN/AVSEEVSee Health 4.00Strong Buy$5.00509.76% UpsideCurrent Analyst Ratings BreakdownLatest NIVF, DHAC, ACON, and VSEE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/30/2025ACONAclarionAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeModerate Buy(Data available from 8/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACONAclarion$50K84.68N/AN/A$24.37 per share0.30DHACDigital Health AcquisitionN/AN/AN/AN/AN/AN/ANIVFNewGenIvf Group$5.43M0.28N/AN/A($146.02) per share-0.01VSEEVSee HealthN/AN/AN/AN/A($3.40) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACONAclarion-$6.99MN/A0.00N/AN/A-11,238.59%-83.63%-76.55%N/ADHACDigital Health AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ANIVFNewGenIvf Group-$520KN/A0.00∞N/AN/AN/AN/AN/AVSEEVSee Health-$4.41MN/A0.00∞N/AN/AN/AN/A9/22/2025 (Estimated)Latest NIVF, DHAC, ACON, and VSEE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025ACONAclarion-$2.26-$2.75-$0.49-$2.75$0.03 million$0.02 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACONAclarionN/AN/AN/AN/AN/ADHACDigital Health AcquisitionN/AN/AN/AN/AN/ANIVFNewGenIvf GroupN/AN/AN/AN/AN/AVSEEVSee HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioACONAclarionN/A23.8321.68DHACDigital Health AcquisitionN/AN/AN/ANIVFNewGenIvf GroupN/A1.171.14VSEEVSee HealthN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACONAclarion7.52%DHACDigital Health Acquisition1.01%NIVFNewGenIvf Group66.24%VSEEVSee Health1.01%Insider OwnershipCompanyInsider OwnershipACONAclarion0.77%DHACDigital Health Acquisition6.59%NIVFNewGenIvf Group31.80%VSEEVSee Health6.59%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACONAclarion7580,000578,000Not OptionableDHACDigital Health Acquisition2,0213.60 million3.37 millionNot OptionableNIVFNewGenIvf GroupN/A865,000590,000N/AVSEEVSee HealthN/A3.60 million3.37 millionN/ANIVF, DHAC, ACON, and VSEE HeadlinesRecent News About These CompaniesVSee Health Faces Nasdaq Delisting Notice1 hour ago | tipranks.comVSee Health, Inc. (NASDAQ:VSEE) Sees Significant Decrease in Short InterestAugust 18, 2025 | americanbankingnews.comVSee Health Appeals NASDAQ Staff Delisting NoticeAugust 12, 2025 | accessnewswire.comAVSee Health stock plummets as Nasdaq delisting loomsAugust 11, 2025 | au.investing.comCORRECTING and REPLACING VSee New AI Doctor Notes Reduces Documentation Time 93% – Transforming Virtual Emergency Care for Tele911July 16, 2025 | businesswire.comVSee Health stock soars after launching AI doctor notes solutionJuly 14, 2025 | in.investing.comVSee Health Stock Jumps After Unveiling AI-Powered Doctor Notes ToolJuly 14, 2025 | msn.comVSee New AI Doctor Notes Reduces Documentation Time 93% – Transforming Virtual Emergency Care for Tele911July 14, 2025 | businesswire.comVSee Health ($VSEE): AI Telehealth Powerhouse Tapped for NIH Stroke Study as It Redefines the $787B Digital Healthcare MarketJune 26, 2025 | theglobeandmail.comVSee Health selected for NIH-funded stroke recovery telerehab trialJune 25, 2025 | investing.comVSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical Trial - Business WireJune 24, 2025 | businesswire.comVSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical TrialJune 23, 2025 | businesswire.comVSee Health faces Nasdaq compliance issue over late filingsJune 1, 2025 | investing.comVSee Health faces Nasdaq delisting over late filingJune 1, 2025 | uk.investing.comVSee Health, Inc. Receives Nasdaq Notice on Delayed Form 10-Q FilingMay 30, 2025 | businesswire.comVSee Health launches telehealth initiative in the PhilippinesMay 17, 2025 | investing.comVSee Health Launches AI-Powered Telehealth to Reduce Maternal Deaths in Remote PhilippinesMay 16, 2025 | businesswire.comVSee Health, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K FilingMay 12, 2025 | businesswire.comVSee Health Inc. Faces Nasdaq Delisting Over Late FilingMay 10, 2025 | investing.comVSee Health unveils AI-driven telenursing platformApril 18, 2025 | uk.investing.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNIVF, DHAC, ACON, and VSEE Company DescriptionsAclarion NASDAQ:ACON$7.30 +0.03 (+0.41%) Closing price 03:49 PM EasternExtended Trading$7.56 +0.26 (+3.49%) As of 06:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.Digital Health Acquisition NASDAQ:DHAC$0.87 +0.04 (+4.82%) As of 08/21/2025Digital Health Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on technology and healthcare focused businesses. Digital Health Acquisition Corp. was incorporated in 2021 and is based in Boca Raton, Florida.NewGenIvf Group NASDAQ:NIVF$1.75 +0.08 (+4.79%) Closing price 04:00 PM EasternExtended Trading$1.72 -0.02 (-1.43%) As of 06:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company was founded by Siu Wing Fung and Fong Hei Yue on January 16, 2019 and is headquartered in Bangkok, Thailand.VSee Health NASDAQ:VSEE$0.82 -0.05 (-5.75%) Closing price 03:47 PM EasternExtended Trading$0.80 -0.01 (-1.83%) As of 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.VSee Health, Inc. is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet’s Breakout Potential: From Laggard to AI Leader After Earnings Miss, Walmart Is Still a Top Consumer Staples Play Should You Join Buffett and Invest in Constellation Brands? Can Identity Security Fuel CrowdStrike’s Next Growth Phase? 3 Robotics Stocks at the Heart of the Robotics Revolution Analog Devices and an AI-Driven Semiconductor Supercycle Shopify’s Risk-Reward Profile Is Suddenly Red Hot 3 Reasons Salesforce Is a Bargain Right Now Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access